Mercodia AB

Immunoassays and Bioanalytical Services

Mercodia AB is a Swedish biotech company focusing on the development and production of immunoassays for research within the field of metabolic disorders, cardiovascular disease and diabetes. Our assays are applicable to both animal and human models and are used for research ranging from basic scientific studies to large pre-clinical and clinical phase trials. Mercodia also offers bioanalytical services according to the latest industry guidelines. The company was founded in 1991 and is today a world-leading supplier of products to all major international markets. More than ninety percent of our production is exported from our facilities in Uppsala to approximately 100 different countries around the world.
CEO
Mona Österberg
Mercodia continuously develops top quality immunoassays within the fields of diabetes, cardiovascular and metabolic disease for researchers worldwide.
  • Category
    Suppliers (Manufactures)
  • Founded
    1991
  • Public company
    No
  • Revenue
    84 MSEK Worldwide
  • Number of employees
    48
  • Chairman
    Erling Holmlund
  • Principal owners
    Erling Holmlund
Patents, projects and products